Platelet-activating factor (PAF) can exert profound inflammatory effects at very low concentrations. In plasma, PAF is hydrolyzed to lyso-PAF by acetylhydrolase, an enzyme that circulates bound to LDL. Previous studies suggest that oxygen radicals may act synergistically with PAF to potentiate tissue injury. However, mechanisms underlying this interaction have not been elucidated. In this study we investigated whether oxygen radicals may inactivate PAF acetylhydrolase. PAF acetylhydrolase activity was measured in human plasma and purified LDL before and after exposure to radicals (10-20 nmol/min per ml) generated by xanthine/xanthine oxidase. Oxygen radicals induced > 50% loss of PAF acetylhydrolase activity within 60 s and almost complete inactivation by 10 min. This phenomenon was irreversible and independent of oxidative modification of LDL. Inactivation occurred without changes in the affinity constant of the enzyme (Km was 17.9 microM under control conditions and 15.1 microM after exposure to oxygen radicals). Inactivation was prevented by the scavengers superoxide dismutase or dimethylthiourea or by the iron chelator deferoxamine. Thus, superoxide-mediated, iron-catalyzed formation of hydroxyl radicals can rapidly and irreversibly inactivate PAF acetylhydrolase. Since concomitant production of PAF and oxygen radicals can occur in various forms of tissue injury, inactivation of acetylhydrolase might represent one mechanism by which oxygen radicals may potentiate and prolong the proinflammatory effects of PAF.
G Ambrosio, A Oriente, C Napoli, G Palumbo, P Chiariello, G Marone, M Condorelli, M Chiariello, M Triggiani
Title and authors | Publication | Year |
---|---|---|
Synergistic Effects of a Novel Combination of Natural Compounds Prevent H2O2-Induced Oxidative Stress in Red Blood Cells
Benincasa G, Bontempo P, Trama U, Napoli C |
International Journal of Molecular Sciences | 2025 |
Micronutrients, Phytochemicals and Mediterranean Diet: A Potential Protective Role against COVID-19 through Modulation of PAF Actions and Metabolism
P Detopoulou, CA Demopoulos, S Antonopoulou |
Nutrients | 2021 |
Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
I Alecu, SA Bennett |
Frontiers in neuroscience | 2019 |
The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in normal and fructose-fed rats
G Wójcicka, M Zaręba, A Warpas, A Jamroz-Wiśniewska, M Rusek, G Czechowska, J Bełtowski |
European Journal of Pharmacology | 2019 |
Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives
R Lordan, A Tsoupras, I Zabetakis, CA Demopoulos |
Molecules (Basel, Switzerland) | 2019 |
Met117 oxidation leads to enhanced flexibility of cardiovascular biomarker- lipoprotein- associated phospholipase A 2 and reduced substrate binding affinity with platelet-activating factor
AB Gurung, A Bhattacharjee |
International Journal of Biological Macromolecules | 2018 |
Platelet-activating factor acetylhydrolase in primary antiphospholipid syndrome
PR Ames, LL Lopez, M Merashli, E Matsuura |
Autoimmunity Highlights | 2018 |
LDL-Related Intolerance to Glucose, Diastolic Hypertension and Additive Effects of Smoking Were Found with Three Female Study Groups
RM Korth |
Health | 2016 |
The Enzymes
DM Stafforini |
Protein Prenylation PART A | 2015 |
Exploiting the anti-inflammatory properties of olive (Olea europaea) in the sustainable production of functional food and neutraceuticals
C Nasopoulou, HC Karantonis, M Detopoulou, CA Demopoulos, I Zabetakis |
Phytochemistry Reviews | 2014 |
Women with overweight, mixed hyperlipidemia, intolerance to glucose and diastolic hypertension
RM Korth |
Health | 2014 |
High-yield enzymatic bioconversion of hydroquinone to α-arbutin, a powerful skin lightening agent, by amylosucrase
DH Seo, JH Jung, SJ Ha, HK Cho, DH Jung, TJ Kim, NI Baek, SH Yoo, CS Park |
Applied Microbiology and Biotechnology | 2012 |
Posztkondicionálás – A távoli szervi dysfunctiók ellenszere?
P Ónody, O Rosero, T Kovács, D Garbaisz, V Hegedüs, G Lotz, L Harsányi, A Szijártó |
Magyar Sebészet (Hungarian Journal of Surgery) | 2012 |
Air plasma for medical applications
SP Kuo |
Journal of Biomedical Science and Engineering | 2012 |
Applications of Air Plasma for Wound Bleeding Control and Healing
SP Kuo, CY Chen, CS Lin, SH Chiang |
IEEE Transactions on Plasma Science | 2012 |
Role of reactive oxygen and nitrogen species in the vascular responses to inflammation
PR Kvietys, DN Granger |
Free radical biology & medicine | 2011 |
Plasma for Bio-Decontamination, Medicine and Food Security
Z Machala, K Hensel, Y Akishev |
2011 | |
Wound Bleeding Control by Low Temperature Air Plasma
SP Kuo, CY Chen, CS Lin, SH Chiang |
IEEE Transactions on Plasma Science | 2010 |
Extracellular phospholipases in atherosclerosis
SA Karabina, S Gora, R Atout, E Ninio |
Biochimie | 2010 |
The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity
G Wójcicka, A Jamroz-Wiśniewska, A Marciniak, E Łowicka, J Bełtowski |
Life Sciences | 2010 |
Blood Clotting by Low-Temperature Air Plasma
CY Chen, HW Fan, SP Kuo, J Chang, T Pedersen, TJ Mills, CC Huang |
IEEE Transactions on Plasma Science | 2009 |
Smoking induces lipoprotein-associated phospholipase A2 in cardiovascular disease free adults: The ATTICA Study
AD Tselepis, DB Panagiotakos, C Pitsavos, CC Tellis, C Chrysohoou, C Stefanadis |
Atherosclerosis | 2009 |
Contribution of a portable air plasma torch to rapid blood coagulation as a method of preventing bleeding
SP Kuo, O Tarasenko, J Chang, S Popovic, CY Chen, HW Fan, A Scott, M Lahiani, P Alusta, JD Drake, M Nikolic |
New Journal of Physics | 2009 |
Mast Cells and Basophils
GH Caughey |
Asthma and COPD | 2009 |
Differential expression of platelet-activating factor acetylhydrolase in lung macrophages
KM Howard |
American journal of physiology. Lung cellular and molecular physiology | 2009 |
Τhe role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma
CC Tellis, AD Tselepis |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2009 |
Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2)
DM Stafforini |
Cardiovascular Drugs and Therapy | 2008 |
Molecular basis for susceptibility of plasma platelet-activating factor acetylhydrolase to oxidative inactivation
AN MacRitchie, AA Gardner, SM Prescott, DM Stafforini |
The FASEB Journal | 2007 |
Plasma PAF-acetylhydrolase: An unfulfilled promise?
SA Karabina, E Ninio |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2006 |
The proinflammatory mediator Platelet Activating Factor is an effective substrate for human group X secreted phospholipase A2
S Gora, G Lambeau, JG Bollinger, M Gelb, E Ninio, SA Karabina |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2006 |
Phospholipid mediators in the vessel wall: involvement in atherosclerosis
E Ninio |
Current Opinion in Clinical Nutrition and Metabolic Care | 2005 |
Plasma platelet-activating factor acetylhydrolase activity in critically ill patients*
RA Claus, S Russwurm, B Dohrn, M Bauer, W L??sche |
Critical Care Medicine | 2005 |
Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase
HC Neto, DM Stafforini, SM Prescott, GA Zimmerman |
Memórias do Instituto Oswaldo Cruz | 2005 |
Release of Free F 2 -isoprostanes from Esterified Phospholipids Is Catalyzed by Intracellular and Plasma Platelet-activating Factor Acetylhydrolases
DM Stafforini, JR Sheller, TS Blackwell, A Sapirstein, FE Yull, TM McIntyre, JV Bonventre, SM Prescott, LJ Roberts |
The Journal of biological chemistry | 2005 |
Occurence of lipid bodies in canine type II pneumocytes during hypothermic lung ischemia
M Ochs, H Fehrenbach, J Richter |
The Anatomical Record | 2004 |
Activation of PAF receptor by oxidised LDL in human monocytes stimulates chemokine releases but not urokinase-type plasminogen activator expression
JL Beaudeux, T Said, E Ninio, F Ganné, J Soria, J Delattre, C Soria, A Legrand, J Peynet |
Clinica Chimica Acta | 2004 |
Plasma platelet activating factor-acetylhydrolase (PAF-AH)
K Karasawa, A Harada, N Satoh, K Inoue, M Setaka |
Progress in Lipid Research | 2003 |
High density lipoprotein can modulate the inhibitory effect of oxLDL on prostacyclin generation by rat aorta in vitro
MM Mahfouz, FA Kummerow |
Prostaglandins & Other Lipid Mediators | 2003 |
Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus
T Kujiraoka, T Iwasaki, M Ishihara, M Ito, M Nagano, A Kawaguchi, S Takahashi, J Ishi, M Tsuji, T Egashira, IP Stepanova, NE Miller, H Hattori |
Journal of lipid research | 2003 |
Role of Monocytes in Atherogenesis
B Østerud, E Bjørklid |
Physiological reviews | 2003 |
Increased free radical production in hypertension due to increased expression of the NADPH oxidase subunit p22phox in lymphoblast cell lines
AI Pettit, RK Wong, V Lee, S Jennings, PA Quinn, LL Ng |
Journal of Hypertension | 2002 |
Role of the interfacial binding domain in the oxidative susceptibility of lecithin:cholesterol acyltransferase
K Wang, PV Subbaiah |
Biochemical Journal | 2002 |
Involvement of reactive oxygen species on gentamicin-induced mesangial cell activation
C Martínez-Salgado, N Eleno, P Tavares, A Rodríguez-Barbero, J García-Criado, JP Bolaños, JM López-Novoa |
Kidney International | 2002 |
The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis
Guy A Zimmerman, Thomas M McIntyre, Stephen M Prescott, Diana M Stafforini |
Critical Care Medicine | 2002 |
Apolipoprotein A-I Milano and Apolipoprotein A-I Paris Exhibit an Antioxidant Activity Distinct from That of Wild-Type Apolipoprotein A-I
JK Bielicki, MN Oda |
Biochemistry | 2002 |
Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice
TM Forte, G Subbanagounder, JA Berliner, PJ Blanche, AO Clermont, Z Jia, MN Oda, RM Krauss, JK Bielicki |
Journal of lipid research | 2002 |
PAF acetylhydrolase gene polymorphisms and asthma severity
DM Stafforini |
Pharmacogenomics | 2001 |
Remodeling of the Vessel Wall after Copper-Induced Injury Is Highly Attenuated in Mice with a Total Deficiency of Plasminogen Activator Inhibitor-1
VA Ploplis, I Cornelissen, MJ Sandoval-Cooper, L Weeks, FA Noria, FJ Castellino |
The American Journal of Pathology | 2001 |
Relative sensitivities of plasma lecithin:cholesterol acyltransferase, platelet-activating factor acetylhydrolase, and paraoxonase to in vitro gas-phase cigarette smoke exposure
JK Bielicki, LJ Knoff, DL Tribble, TM Forte |
Atherosclerosis | 2001 |
The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase
TW Kuijpers, JM van Berg, AT Tool, D Roos |
Clinical & Experimental Immunology | 2001 |
Trimetazidine protects low-density lipoproteins from oxidation and cultured cells exposed to H2O2 from DNA damage
A Tselepis, PT Doulias, E Lourida, G Glantzounis, E Tsimoyiannis, D Galaris |
Free radical biology & medicine | 2001 |
Environmental Stressors in Health and Disease
B Halliwell |
Environmental Stressors in Health and Disease | 2001 |
Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia
R Jehle, M Schlame, C Büttner, B Frey, P Sinha, B Rüstow |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2001 |
Roles for platelet-activating factor and ·NO-derived oxidants causing neutrophil adherence after CO poisoning
SR Thom, D Fisher, Y Manevich |
American journal of physiology. Heart and circulatory physiology | 2001 |
Adenovirus-Mediated Gene Transfer of Human Platelet-Activating Factor–Acetylhydrolase Prevents Injury-Induced Neointima Formation and Reduces Spontaneous Atherosclerosis in Apolipoprotein E–Deficient Mice
R Quarck, BD Geest, D Stengel, A Mertens, M Lox, G Theilmeier, C Michiels, M Raes, H Bult, D Collen, PV Veldhoven, E Ninio, P Holvoet |
Circulation | 2001 |
Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome
F Trimoreau, B François, A Desachy, A Besse, P Vignon, Y Denizot |
Mediators of Inflammation | 2000 |
Platelet-activating factor acetylhydrolases in health and disease
LW Tjoelker, DM Stafforini |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 2000 |
Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells
C Napoli, O Quehenberger, FD Nigris, P Abete, CK Glass, W Palinski |
The FASEB Journal | 2000 |
Deregulated platelet‐activating factor levels and acetylhydrolase activity in patients with idiopathic IgA nephropathy
Y Denizot, C Aupetit, F Bridoux, JC Alphonse, M Cogné, JC Aldigier |
Nephrology Dialysis Transplantation | 2000 |
Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma
DM Stafforini, T Numao, A Tsodikov, D Vaitkus, T Fukuda, N Watanabe, N Fueki, TM McIntyre, GA Zimmerman, S Makino, SM Prescott |
Journal of Clinical Investigation | 1999 |
Role of oxidatively modified low density lipoproteins and anti-oxidants in atherothrombosis
P Holvoet |
Expert Opinion on Investigational Drugs | 1999 |
Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers
PV Peplow |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 1999 |
Beneficial effects of ACE-inhibition with zofenopril on plaque formation and low-density lipoprotein oxidation in watanabe heritable hyperlipidemic rabbits
C Napoli, C Cicala, FP D'Armiento, F Roviezzo, P Somma, F Nigris, P Zuliani, M Bucci, L Aleotti, A Casini, F Franconi, G Cirino |
General Pharmacology: The Vascular System | 1999 |
Reperfusion injury: Experimental evidence and clinical implications
G Ambrosio, I Tritto |
American Heart Journal | 1999 |
Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-l-carnitine
M Triggiani, A Oriente, P Golino, M Gentile, C Battaglia, G Brevetti, G Marone |
Biochemical Pharmacology | 1999 |
Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma
VS Subramanian, J Goyal, M Miwa, J Sugatami, M Akiyama, M Liu, PV Subbaiah |
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids | 1999 |
Augmentation of Ultraviolet B Radiation-induced Tumor Necrosis Factor Production by the Epidermal Platelet-activating Factor Receptor
LC Dy, Y Pei, JB Travers |
The Journal of biological chemistry | 1999 |
1,4-Dihydropyridine Calcium Channel Blockers Inhibit Plasma and LDL Oxidation and Formation of Oxidation-Specific Epitopes in the Arterial Wall and Prolong Survival in Stroke-Prone Spontaneously Hypertensive Rats
C Napoli, S Salomone, T Godfraind, W Palinski, DM Capuzzi, G Palumbo, FP DArmiento, R Donzelli, F de Nigris, RL Capizzi, M Mancini, JS Gonnella, A Bianchi |
Stroke; a journal of cerebral circulation | 1999 |
Roles of Plasma Platelet-Activating Factor Acetylhydrolase in Allergic, Inflammatory, and Atherosclerotic Diseases
Y Yamada, M Yokota |
Japanese Circulation Journal | 1998 |
Plasma platelet-activating factor levels in newborn infants with and without perinatal asphyxia: Is it an additional marker of perinatal asphyxia?
M AkisÜ, NÜ KÜLtÜRsay, I ÇOker, A HÜSeyinov |
Pediatrics International | 1998 |
Involvement of superoxide and nitric oxide on airway inflammation and hyperresponsiveness induced by diesel exhaust particles in mice
HB Lim, T Ichinose, Y Miyabara, H Takano, Y Kumagai, N Shimojyo, JL Devalia, M Sagai |
Free radical biology & medicine | 1998 |
Oxidation of low density lipoproteins in the pathogenesis of atherosclerosis
P Holvoet, D Collen |
Atherosclerosis | 1998 |
Familial hypercholesterolaemia and platelet-activating factor acetylhydrolase: difference between the homozygous and heterozygous form
Napoli |
European Journal of Clinical Investigation | 1998 |
High density associated enzymes: their role in vascular biology
M Navab, SY Hama, GP Hough, CC Hedrick, R Sorenson, BN la Du, JA Kobashigawa, GC Fonarow, JA Berliner, H Laks, AM Fogelman |
Current Opinion in Lipidology | 1998 |
Secretory PAF-acetylhydrolase of the rat hepatobiliary system: characterization and partial purification
SI Svetlov, KM Howard, MS Debuysere, MS Olson |
AJP Gastrointestinal and Liver Physiology | 1998 |
Expression of the Platelet-activating Factor Receptor Results in Enhanced Ultraviolet B Radiation-induced Apoptosis in a Human Epidermal Cell Line
LA Barber, DF Spandau, SC Rathman, RC Murphy, CA Johnson, SW Kelley, SA Hurwitz, JB Travers |
The Journal of biological chemistry | 1998 |
Yearbook of Intensive Care and Emergency Medicine 1998
JL Vincent |
1998 | |
Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions
C Napoli, FP D'Armiento, FP Mancini, A Postiglione, JL Witztum, G Palumbo, W Palinski |
Journal of Clinical Investigation | 1997 |
Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein
C Napoli, M Triggiani, G Palumbo, M Condorelli, M Chiariello, G Ambrosio |
Basic Research in Cardiology | 1997 |
Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein
A Graham, DG Hassall, S Rafique, JS Owen |
Atherosclerosis | 1997 |
Effect of low density lipoprotein fatty acid composition on copper-induced peroxidation: 1H-nuclear magnetic resonance analysis
G Corso, E Trivellone, A Motta, A Postiglione, FP Mancinia, V Carbone, C Napoli |
Clinica Chimica Acta | 1997 |
Platelet-Activating Factor (PAF) Up-Regulates Plasma and Tissue PAF-Acetylhydrolase Activity in the Rat: Effect of Cycloheximide
H Wang, XD Tan, XW Qu, H Chang, DG Remick, F Gonzalez-Crussi, W Hsueh |
Pediatric Research | 1997 |
Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia
C Napoli, G Ambrosio, N Scarpato, G Corso, G Palumbo, FP D'Armiento, FP Mancini, A Malorni, S Formisano, A Ruocco, A Calí, M Chiariello |
American Heart Journal | 1997 |
Role of Platelet-Actlvatlng-Factor (PAF) on Cellular Responses after Stimulation with Leptospire Lipopolysaccharide
E Isogai, K Hirose, K Kimura, S Hayashi, T Kubota, N Fujii, H Isogai |
Microbiology and Immunology | 1997 |
Characterization of Platelet-activating Factor Acetylhydrolase in Human Bronchoalveolar Lavage
M Triggiani, VA MARINO, M Sofia, S Faraone, G Ambrosio, L Carratù, G Marone |
American journal of respiratory and critical care medicine | 1997 |
Occurrence of the same peroxidative compounds in low density lipoprotein and in atherosclerotic lesions from a homozygous familial hypercholesterolemic patient: a case report
C Napoli, FP D'Armiento, G Corso, G Ambrosio, G Palumbo, P Zuliani, A Malorni, G Gallotta, S Somma, A Postiglione, M Chiariello |
International Journal of Cardiology | 1997 |
Loss of ATP Diphosphohydrolase Activity with Endothelial Cell Activation
SC Robson, E Kaczmarek, JB Siegel, D Candinas, K Koziak, M Millan, WW Hancock, FH Bach |
Journal of Experimental Medicine | 1997 |
Novel Function of Lecithin-Cholesterol Acyltransferase: HYDROLYSIS OF OXIDIZED POLAR PHOSPHOLIPIDS GENERATED DURING LIPOPROTEIN OXIDATION
J Goyal, K Wang, M Liu, PV Subbaiah |
The Journal of biological chemistry | 1997 |
Platelet-activating Factor Acetylhydrolases
DM Stafforini, TM McIntyre, GA Zimmerman, SM Prescott |
The Journal of biological chemistry | 1997 |
Mildly Oxidized Low-Density Lipoprotein Impairs Responses of Carotid but Not Basilar Artery in Rabbits
C Napoli, R Paternò, FM Faraci, H Taguchi, A Postiglione, DD Heistad |
Stroke; a journal of cerebral circulation | 1997 |
Reactive Oxygen Species and Platelet Activation in Reperfusion Injury
RC Forde, DJ Fitzgerald |
Circulation | 1997 |
Oxygen Radicals Can Induce Preconditioning in Rabbit Hearts
I Tritto, D DAndrea, N Eramo, A Scognamiglio, CD Simone, A Violante, A Esposito, M Chiariello, G Ambrosio |
Circulation research | 1997 |
Ecto-ATPases
L Plesner, TL Kirley, AF Knowles |
1997 | |
Mammalian platelet-activating factor acetylhydrolases
D Stafforini |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1996 |
Biological effects of diesel exhaust particles (DEP). III. Pathogenesis of asthma like symptoms in mice
M Sagai, A Furuyama, T Ichinose |
Free radical biology & medicine | 1996 |
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion
P Golino, M Ragni, P Cirillo, VE Avvdimento, A Feliciello, N Esposito, A Scognamiglio, B Trimarco, G Iaccarino, M Condorelli, M Chiariello, G Ambrosio |
Nature Medicine | 1996 |
Platelet-activating-factor-mediated pathogenesis in Lyme disease
E Isogai, K Kimura, N Fujii, T Nishikawa, N Ishii, D Postic, G Baranton, H Isogai |
Infection and immunity | 1996 |
Low density lipoprotein oxidation and variant angina: Role of methodologic procedures in assessment of oxidizability of low density lipoprotein
C Napoli |
Journal of the American College of Cardiology | 1996 |
APYRASE ADMINISTRATION PROLONGS DISCORDANT XENOGRAFT SURVIVAL1,2,3,4:
N Koyamada, T Miyatake, D Candinas, P Hechenleitner, J Siegel, WW Hancock, FH Bach, SC Robson |
Transplantation | 1996 |
The Yin and Yang of Oxidation in the Development of the Fatty Streak: A Review Based on the 1994 George Lyman Duff Memorial Lecture
M Navab, JA Berliner, AD Watson, SY Hama, MC Territo, AJ Lusis, DM Shih, BJ Lenten, JS Frank, LL Demer, PA Edwards, AM Fogelman |
Arteriosclerosis, thrombosis, and vascular biology | 1996 |
Calcium-channel blockers inhibit human low-density lipoprotein oxidation by oxygen radicals
C Napoli, M Chiariello, G Palumbo, G Ambrosio |
Cardiovascular Drugs and Therapy | 1996 |
Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein
AD Watson, M Navab, SY Hama, A Sevanian, SM Prescott, DM Stafforini, TM McIntyre, BN Du, AM Fogelman, JA Berliner |
Journal of Clinical Investigation | 1995 |
Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells
JM Heery, M Kozak, DM Stafforini, DA Jones, GA Zimmerman, TM McIntyre, SM Prescott |
Journal of Clinical Investigation | 1995 |
Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia
C Napoli, A Postiglione, M Triggiani, G Corso, G Palumbo, V Carbone, A Ruocco, G Ambrosio, S Montefusco, A Malorni, M Condorelli, M Chiariello |
Atherosclerosis | 1995 |
Platelet-activating factor: a mediator for clinicians
TA Imaizumi, DM Stafforini, Y Yamada, TM Mcintyre, SM Prescott, GA Zimmerman |
Journal of Internal Medicine | 1995 |
Cellular Signals in Alcohol-Induced Liver Injury: A Review
WE Lands |
Alcoholism, clinical and experimental research | 1995 |
A family of phospholipid autacoids: Occurrence, metabolism and bioactions
A Tokumura |
Progress in Lipid Research | 1995 |
Patent Update: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Platelet-activating factor receptor antagonists
A Ayscough, M Whittaker |
Expert Opinion on Therapeutic Patents | 1995 |